Bio Essence Corp. (BIOE) intrinsic value & 10-year financials
Bio Essence Corp. (BIOE) has a Graham intrinsic value of $0.77 per share. At $0.39 on Oct 17, 2026, the stock trades 49% below that value. Over the last 7 fiscal years revenue grew 14.6% a year to $1.9M, with an average return on invested capital of 87.7%.
- Graham intrinsic value
- $0.77
- Share price (Oct 17, 2026)
- $0.39
- Price vs Graham value
- 49% below
- Market cap
- $14.8M
- Revenue (FY2025)
- $1.9M
- Revenue growth (7-yr CAGR)
- 14.6%
- ROIC (10-yr avg)
- 87.7%
- Free cash flow (FY2025)
- —
BIOE 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.9M | $896.2K | — | — | 47.4% | -35.7% |
| FY2024 | $323.9K | -$1.3M | -$0.03 | — | -141.8% | 28.3% |
| FY2023 | $551.5K | -$971.9K | -$0.02 | -$1.0M | -143.1% | 53.1% |
| FY2022 | $621.6K | -$809.7K | -$0.02 | -$710.6K | -125.9% | 64.3% |
| FY2021 | $888.0K | -$647.6K | -$0.02 | -$1.4M | -96.6% | 250.3% |
| FY2020 | $958.7K | -$595.8K | — | -$740.1K | -86.8% | 165.9% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Bio Essence Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Bio Essence Corp has earned high returns on invested capital, averaging 19.0% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Bio Essence Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Bio Essence Corp is modeled at 14.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.77 per share.